Literature DB >> 10959541

Effects of d-amphetamine and ethanol on a measure of behavioral inhibition in humans.

H de Wit1, J Crean, J B Richards.   

Abstract

Little is known about the acute effects of psychoactive drugs on impulsivity and decision making in humans. This study examined the effects of d-amphetamine (AMP; 10 and 20 mg; N = 20) and ethanol (EtOH; 0.2, 0.4, and 0.8 g/kg; N = 17) on the stop task, a putative measure of behavioral inhibition and impulsivity in healthy human volunteers. The stop task provides a measure of the reaction time (RT) needed to inhibit a response (Stop RT [SRT]), relative to the time taken to execute a simple response (Go RT [GRT]). Healthy volunteers performed the stop task before and after receiving one of the drugs. AMP decreased SRT-that is, improved inhibition-only in participants with slow baseline SRTs. EtOH increased SRTs-that is, impaired inhibition-at doses that did not affect GRTs. These results suggest that AMP and EtOH have specific and distinctive effects on the ability to inhibit responses. Impairment in the ability to inhibit responses is thought to reflect a certain form of impulsivity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10959541     DOI: 10.1037//0735-7044.114.4.830

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  105 in total

1.  Manipulation of nicotinic acetylcholine receptors differentially affects behavioral inhibition in human subjects with and without disordered baseline impulsivity.

Authors:  Alexandra S Potter; David J Bucci; Paul A Newhouse
Journal:  Psychopharmacology (Berl)       Date:  2011-10-04       Impact factor: 4.530

2.  Striatal D1- and D2-type dopamine receptors are linked to motor response inhibition in human subjects.

Authors:  Chelsea L Robertson; Kenji Ishibashi; Mark A Mandelkern; Amira K Brown; Dara G Ghahremani; Fred Sabb; Robert Bilder; Tyrone Cannon; Jacqueline Borg; Edythe D London
Journal:  J Neurosci       Date:  2015-04-15       Impact factor: 6.167

3.  Effects of d-amphetamine in human models of information processing and inhibitory control.

Authors:  Mark T Fillmore; Thomas H Kelly; Catherine A Martin
Journal:  Drug Alcohol Depend       Date:  2005-02-14       Impact factor: 4.492

4.  Behavioral inhibition in mice bred for high vs. low levels of methamphetamine consumption or sensitization.

Authors:  Travis M Moschak; Katherine A Stang; Tamara J Phillips; Suzanne H Mitchell
Journal:  Psychopharmacology (Berl)       Date:  2012-02-04       Impact factor: 4.530

5.  Protracted impairment of impulse control under an acute dose of alcohol: a time-course analysis.

Authors:  Melissa A Miller; Mark T Fillmore
Journal:  Addict Behav       Date:  2013-11-08       Impact factor: 3.913

6.  Test-retest reliability of behavioral measures of impulsive choice, impulsive action, and inattention.

Authors:  Jessica Weafer; Matthew J Baggott; Harriet de Wit
Journal:  Exp Clin Psychopharmacol       Date:  2013-10-07       Impact factor: 3.157

7.  Substance abuser impulsivity decreases with a nine-month stay in a therapeutic community.

Authors:  Susan M Bankston; Deidra D Carroll; Stanley G Cron; L Kian Granmayeh; Marianne T Marcus; F Gerard Moeller; Joy M Schmitz; Paul Swank; Patricia R Liehr
Journal:  Am J Drug Alcohol Abuse       Date:  2009       Impact factor: 3.829

8.  Alcohol attenuates amygdala-frontal connectivity during processing social signals in heavy social drinkers: a preliminary pharmaco-fMRI study.

Authors:  Stephanie M Gorka; Daniel A Fitzgerald; Andrea C King; K Luan Phan
Journal:  Psychopharmacology (Berl)       Date:  2013-04-13       Impact factor: 4.530

Review 9.  Impulsivity as a determinant and consequence of drug use: a review of underlying processes.

Authors:  Harriet de Wit
Journal:  Addict Biol       Date:  2008-10-09       Impact factor: 4.280

10.  Evaluation of genetic variability in the dopamine receptor D2 in relation to behavioral inhibition and impulsivity/sensation seeking: an exploratory study with d-amphetamine in healthy participants.

Authors:  Ajna Hamidovic; Andrea Dlugos; Andrew Skol; Abraham A Palmer; Harriet de Wit
Journal:  Exp Clin Psychopharmacol       Date:  2009-12       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.